CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 54 filers reported holding CASI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $92,000 | -18.6% | 38,529 | +0.3% | 0.00% | – |
Q4 2020 | $113,000 | +85.2% | 38,427 | -2.8% | 0.00% | – |
Q3 2020 | $61,000 | -25.6% | 39,530 | +20.1% | 0.00% | – |
Q2 2020 | $82,000 | +34.4% | 32,918 | +10.3% | 0.00% | – |
Q1 2020 | $61,000 | -37.8% | 29,851 | -5.5% | 0.00% | – |
Q4 2019 | $98,000 | -7.5% | 31,576 | -0.8% | 0.00% | – |
Q3 2019 | $106,000 | +2.9% | 31,842 | -0.7% | 0.00% | – |
Q2 2019 | $103,000 | +13.2% | 32,064 | +0.8% | 0.00% | – |
Q1 2019 | $91,000 | -31.1% | 31,822 | -3.1% | 0.00% | -100.0% |
Q4 2018 | $132,000 | -14.8% | 32,854 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $155,000 | -42.2% | 33,105 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $268,000 | – | 32,509 | +24906.9% | 0.00% | – |
Q1 2016 | $0 | – | 130 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 130 | 0.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 130 | 0.0% | 0.00% | – |
Q2 2015 | $233,000 | +21.4% | 130 | 0.0% | 0.00% | – |
Q1 2015 | $192,000 | +262.3% | 130 | +225.0% | 0.00% | – |
Q4 2014 | $53,000 | -26.4% | 40 | 0.0% | 0.00% | – |
Q3 2014 | $72,000 | – | 40 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
Perceptive Advisors | 43,682 | $204,000 | 0.01% |
ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |